Vietnam Sun Corporation (HOSE:VNS)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	665,020	705,736	895,741	1,167,178	763,416	743,058
Market Cap Growth	-13.06%	-21.21%	-23.26%	52.89%	2.74%	2.34%
Enterprise Value	867,604	841,077	783,281	845,539	671,792	995,925
Last Close Price	9800.00	9445.87	10616.21	10825.18	7080.43	6891.61
PE Ratio	8.80	8.46	5.97	6.37	-	-
Forward PE	-	7.22	7.22	7.22	7.22	7.22
PS Ratio	0.69	0.70	0.74	1.07	1.58	0.74
PB Ratio	0.57	0.61	0.77	0.84	0.63	0.50
P/TBV Ratio	0.57	0.61	0.77	0.85	0.64	0.50
P/FCF Ratio	-	-	6.62	144.24	-	8.91
P/OCF Ratio	2.93	3.35	2.82	3.37	47.42	6.84
PEG Ratio	-	0.42	0.42	0.42	0.42	0.42
EV/Sales Ratio	0.91	0.84	0.64	0.78	1.39	0.99
EV/EBITDA Ratio	3.52	3.41	2.38	2.47	42.65	7.51
EV/EBIT Ratio	27.80	29.40	8.10	5.70	-	-
EV/FCF Ratio	-1.71	-	5.79	104.49	-	11.95
Debt / Equity Ratio	0.43	0.48	0.25	0.18	0.16	0.23
Debt / EBITDA Ratio	1.91	2.25	0.88	0.71	11.98	2.58
Debt / FCF Ratio	-	-	2.14	30.09	-	4.10
Asset Turnover	0.55	0.57	0.70	0.64	0.27	0.43
Inventory Turnover	80.58	91.62	110.41	88.75	55.72	72.01
Quick Ratio	1.15	1.39	2.96	3.86	2.60	1.34
Current Ratio	1.22	1.52	3.10	4.09	2.78	1.45
Return on Equity (ROE)	6.26%	7.26%	11.85%	14.31%	-20.61%	-13.25%
Return on Assets (ROA)	1.37%	1.02%	3.46%	5.44%	-8.90%	-6.55%
Return on Capital (ROIC)	1.54%	1.13%	3.92%	6.13%	-10.03%	-7.51%
Return on Capital Employed (ROCE)	2.50%	1.80%	6.60%	8.90%	-	-
Earnings Yield	11.36%	11.91%	16.83%	15.75%	-35.78%	-27.86%
FCF Yield	-76.24%	-75.38%	15.12%	0.69%	-2.32%	11.22%
Dividend Yield	10.17%	-	42.39%	7.39%	-	-
Payout Ratio	133.52%	121.01%	238.47%	0.02%	-	-
Total Shareholder Return	9.76%	-	42.39%	7.39%	-	-

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.